Stock CERENIS THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cerenis Therapeutics LIQUIDNET SYSTEMS

Equities

FR0012616852

End-of-day quote LIQUIDNET SYSTEMS
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cerenis Therapeutics -.--% -.--%
Mar. 14 Abionyx Pharma: to benefit from a 1ME grant from Bpifrance CF
Mar. 11 Abionyx: reduced net loss in 2023 CF

Evolution of the average Target Price on Cerenis Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

ee7.AjL0fNHihrk3smcQI5Gb87kbreDJF3OI-g3LMb2V7kw.V3qkRL6A5NMD1lJUFan6pchIgI6ITwr4zWSyZIniuQZAXsdRhJf1yWD-Pg~72d7366cf01881d3a145212ecd9f2fef

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.248 EUR
Average target price
10.5 EUR
Spread / Average Target
+741.35%
High Price Target
10.5 EUR
Spread / Highest target
+741.35%
Low Price Target
10.5 EUR
Spread / Lowest Target
+741.35%

Consensus detail

Consensus revision (last 18 months)

Ratings for Cerenis Therapeutics

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ABNX Stock
  4. Stock
  5. Consensus Cerenis Therapeutics